Abstract
Leaded fuel emissions exposed a global population of children to lead and its profound health consequences. Recognition of its harms precipitated a global phase out and replacement with unleaded substitutes for road vehicles. Despite this widespread recognition and action, aviation fuel for piston engine aircraft still contains lead. Leaded aviation fuel (AVGAS100LL) contains 0.56g of tetraethyl lead per litre and this lead must be jettisoned from the engine during operation to prevent fouling. This action distributes lead and lead compounds into the air and soil around general aviation airports. This has been shown to increase the blood lead levels of children living nearby to clinically significant levels. Whilst this problem is recognised by the EPA in the U.S, it has received little attention in the UK. We provide a review of the situation in the UK with regard to the current policy and regulation framework. We analysed the UK’s general aviation airport fleet, general avation airport data, and GB residential address data. We estimate the unleaded-readiness of the UK aviation fleet and the current usage of fuels at UK general aviation airports. We provide a first order estimate of the number of residential addresses exposed to lead near general aviation airports. We find that the majority of aviation fuel sold in the UK is leaded and that there are 370721 residences within 4km of a general aviation airport at risk from exposure to lead emissions. Finally we present a path forward for regulation change and public health monitoring.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
An unfinished paragraph was detected and finished.
Data Availability
The postcode sector polygon data are available from the University of Edinburgh DataShare platform (https://doi.org/10.7488/ds/1947). This is a publicly available dataset. The residential address data used were obtained by license from the Ordnance Survey via their AddressBase Core product (https://www.ordnancesurvey.co.uk/business-government/products/addressbase-core). This is a paid-for product but is available under a free license for research purposes, on a per-application basis. The list of registered UK aircraft and their details can be obtained by contacting the CAA directly (https://www.caa.co.uk/home/).
https://doi.org/10.7488/ds/1947
https://www.ordnancesurvey.co.uk/business-government/products/addressbase-core